To evaluate the impact of using clinical stage assessed by multi-parametric magnetic resonance imaging (mpMRI) on the performance of two established nomograms for prediction of lymph node involvement (LNI) in patients with prostate cancer.
To evaluate the impact of using clinical stage assessed by multi-parametric magnetic resonance imaging (mpMRI) on the performance of two established nomograms for prediction of lymph node involvement (LNI) in patients with prostate cancer.